RADX (RADX)
4.29
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form 424B5 Radiopharm Theranostics
July 23, 2026 9:09 AM - SEC Filing
Radiopharm reports partial response in RAD204 cancer drug trial
July 22, 2026 7:05 AM - StreetInsider
Radiopharm Theranostics Achieves Confirmed Durable Partial Response in Ongoing Phase 1 Trial of RAD204 in Patients with Advanced Solid Tumors Post-Immunotherapy
July 22, 2026 7:05 AM - Globe NewsWire
Radiopharm RAD101 meets Phase 2b endpoint for brain metastases
July 22, 2026 7:00 AM - StreetInsider
Form 6-K Radiopharm Theranostics For: Jul 22
July 22, 2026 7:00 AM - SEC Filing
Radiopharm Theranostics Announces Positive Phase 2b Trial Results of RAD 101 for Diagnosis of Brain Metastases
July 22, 2026 7:00 AM - Globe NewsWire
Form 6-K Radiopharm Theranostics For: Jul 03
July 6, 2026 7:00 AM - SEC Filing
Form 6-K Radiopharm Theranostics For: Jun 30
June 30, 2026 9:11 AM - SEC Filing
H.C. Wainwright Starts Radiopharm Theranostics (RADX) at Buy
June 4, 2026 6:07 AM - StreetInsider
Form 6-K Radiopharm Theranostics For: Jun 03
June 3, 2026 8:00 AM - SEC Filing
A Cancer Antigen Long Thought Untouchable Is Suddenly the Hottest Target in Oncology
May 14, 2026 9:15 AM - StreetInsider
Form 3 Radiopharm Theranostics For: Mar 18 Filed by: Voliotis Dimitris
May 6, 2026 9:09 PM - SEC Filing
Form 3 Radiopharm Theranostics For: Mar 18 Filed by: HOPPER PAUL
May 6, 2026 6:08 AM - SEC Filing
Form 3 Radiopharm Theranostics For: Mar 18 Filed by: Laurita Aaron James
April 30, 2026 9:52 PM - SEC Filing
Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing
April 29, 2026 8:35 AM - Globe NewsWire
Full Article List
